Principles of Immunology, Genetics, and Molecular Diagnostics

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/49

flashcard set

Earn XP

Description and Tags

A set of 50 vocabulary flashcards covering basic immunology, autoimmune diseases, antinuclear antibodies, genetics, molecular diagnostics, and precision oncology.

50 Terms

1
New cards

Primary Lymphoid Organs

Sites where lymphocytes develop, specifically the bone marrow for B cells and the thymus for T cells.

2
New cards

Secondary Lymphoid Organs

Sites where immune responses are initiated and maintained, including the lymph nodes, spleen, and mucosal-associated lymphoid tissue (MALT).

3
New cards

Affinity

The attractive force between a single epitope and an antibody binding site.

4
New cards

Avidity

The sum of total attractive forces between a multivalent antigen and an antibody.

5
New cards

Fab Region

The variable region of an antibody responsible for highly specific antigen binding.

6
New cards

Fc Region

The constant region of an antibody responsible for immune effector functions.

7
New cards

Neutralization

An antibody effector mechanism that eliminates pathogens by preventing adherence.

8
New cards

Opsonization

An antibody effector mechanism that enhances pathogen phagocytosis via Fc receptors.

9
New cards
<p>IgG Molecule Structure</p>

IgG Molecule Structure

A 150 kDa150\,\text{kDa} immunoglobulin structure comprising paired heavy and light chain domains divided into Fab, Fv, and Fc functional regions.

10
New cards

Correlate of Protection

Vaccine-induced binding antibodies against the viral spike protein whose titer levels can predict protection from infection.

11
New cards

Synthetic Monoclonal Antibody Therapies

Therapies targeting specific conserved epitopes on the SARS-CoV-2 spike protein receptor-binding domain (RBD).

12
New cards

Type I Hypersensitivity

An immediate, anaphylactic/allergic reaction mediated by IgE binding to soluble antigens on mast cells and basophils.

13
New cards

Type II Hypersensitivity

An immediate reaction involving IgG or IgM targeting cell-surface antigens or receptors, leading to complement activation or phagocytosis.

14
New cards

Type III Hypersensitivity

An immune complex-mediated reaction driven by IgG or IgM complexes formed with soluble antigens that deposit in tissues and activate complement or phagocytes.

15
New cards

Type IV Hypersensitivity

A delayed reaction (24–72 hours24\text{--}72\,\text{hours}) mediated by T cells (Th1\text{Th1}, Th2\text{Th2}, CTL) and macrophages without antibodies.

16
New cards

Innate Immunity

Immune defense that acts within minutes to hours, recognizes shared structural patterns, possesses limited diversity, and generally lacks immunological memory.

17
New cards

Adaptive Immunity

Antigen-specific immune defense that takes days to respond, possesses an extremely large diversity (101810^{18}), and exhibits robust immunological memory.

18
New cards

B Cells

Lymphocytes that originate and develop in the bone marrow, recognize antigens via B-cell receptors, and function in antibody production, antigen presentation, neutralization, opsonization, and complement activation.

19
New cards

T Cells

Lymphocytes that originate in the bone marrow, develop in the thymus, recognize peptide antigens presented via MHC molecules using T-cell receptors, and function in cell killing and cytokine secretion.

20
New cards

Hypergammaglobulinemia

An elevation of immunoglobulins that can be polyclonal (reactive to infection or inflammation) or monoclonal (resulting from a clonal expansion of plasma cells or B cells).

21
New cards

Multiple Myeloma

A plasma cell neoplasm that can progress from non-IgM MGUS, diagnosed and confirmed via serum protein electrophoresis (SPEP) and immunofixation.

22
New cards

CRAB Mnemonic

A clinical summary of end-organ damage in multiple myeloma: Hypercalcemia (C), Renal dysfunction (R), Anemia (A), and Lytic bone lesions / bone pain (B).

23
New cards

Waldenström's Macroglobulinemia

An indolent lymphoplasmacytic lymphoma characterized by overproduction of monoclonal pentameric IgM, causing hyperviscosity syndrome.

24
New cards

Clonal Deletion

The elimination of immature lymphocytes expressing self-reactive receptors via apoptosis in primary lymphoid organs to prevent autoimmunity.

25
New cards

Rheumatoid Factors (RF)

Autoantibodies targeting the constant (Fc) region of IgG, present in 70–80%70\text{--}80\% of rheumatoid arthritis patients but possessing low diagnostic specificity.

26
New cards

Anti-Citrullinated Protein Antibodies (anti-CCP / ACPA)

Autoantibodies directed against citrullinated proteins that exhibit high diagnostic specificity (>90%>90\%) for rheumatoid arthritis.

27
New cards

Indirect Immunofluorescence Assay (IIFA)

The established gold standard screening technique for ANA detection utilizing HEp-2 cells and fluoresceinated anti-IgG antibodies visualized under a fluorescence microscope.

28
New cards

Homogeneous ANA Pattern

A nuclear staining pattern associated with systemic lupus erythematosus (SLE) and drug-induced lupus that targets dsDNA, histones, and nucleosomes.

29
New cards

Speckled ANA Pattern

An ANA staining pattern associated with SLE, systemic sclerosis, Sjögren's syndrome, MCTD, and inflammatory myopathies that targets extractable nuclear antigens (Sm, RNP, Ro/SSA, La/SSB).

30
New cards

Nucleolar ANA Pattern

An ANA staining pattern associated with systemic sclerosis and SLE that targets nucleolar components and Scl-70.

31
New cards

Peripheral (Rim) ANA Pattern

An ANA staining pattern targeting dsDNA that is highly associated with systemic lupus erythematosus (SLE).

32
New cards

Centromere ANA Pattern

An ANA staining pattern targeting centromeric proteins (CENP-A, B, C, D) that is highly associated with CREST syndrome (limited scleroderma).

33
New cards

ANA Titer

The highest serial dilution of patient serum that still yields a positive fluorescence signal, providing semi-quantitative information on autoantibody levels.

34
New cards

Protein-Coding Genes

Sequences that make up approximately 1.5%1.5\% of the human genome, with the remaining majority consisting of non-coding regions and repetitive elements.

35
New cards

Central Dogma

The biological principle describing the flow of genetic information within a biological system from DNA→mRNA→Protein\text{DNA} \rightarrow \text{mRNA} \rightarrow \text{Protein}.

36
New cards

DNA Replication

The synthesis of a complete DNA copy of an entire chromosome for cell division via mitosis or meiosis.

37
New cards

RNA Transcription

The process of copying a specific section of DNA into single-stranded RNA, including pre-mRNA splicing to remove introns and addition of a protective cap and tail.

38
New cards

RNA Translation

The ribosomal process of translating an mRNA sequence into an amino acid chain, where unique R-groups dictate structure and function.

39
New cards

Carrier Genetic Testing

Testing performed on asymptomatic individuals for recessive conditions to understand reproductive risks.

40
New cards

Presymptomatic Genetic Testing

Genetic testing performed to detect variants associated with genetic conditions before symptoms start to manifest.

41
New cards

Pharmacogenetic Testing

Genetic testing assessing how an individual's genetic profile impacts drug metabolism and response.

42
New cards

Genetic Information Nondiscrimination Act (GINA)

Legislation protecting individuals from genetic discrimination in employment and health coverage, but not applying to life insurance, disability insurance, or the military.

43
New cards

Bacterial Genome

A singular circular chromosome (3–6 Mb3\text{--}6\,\text{Mb}) containing 4,000–5,0004{,}000\text{--}5{,}000 genes and self-replicating extrachromosomal plasmids.

44
New cards

Antigenic Drift

Gradual changes in viral antigens caused by high mutation frequencies when viruses hijack host cell machinery to replicate.

45
New cards

Antigenic Shift

Major alterations resulting from genomic segment reassortment when host cells are co-infected by different viruses.

46
New cards

Pathogen-Specific Assays

Assays that target a unique, organism-specific nucleic acid sequence with high sensitivity to detect a single pathogen.

47
New cards

Broad-Range Assays

Assays targeting a polymorphic gene sequence shared across a class of organisms combined with DNA sequencing to identify unknown or unexpected pathogens.

48
New cards

Metagenomic Approaches

Unbiased sequencing of all DNA in a patient specimen using massive read counts to identify bacteria, viruses, or parasites.

49
New cards

Pathogen Load Assays

Quantitative assays (such as quantitative RT-PCR or ddPCR) that measure amounts of a pathogen over time to monitor treatment response.

50
New cards

Biomarker

A measurable biological clue about a cancer—such as a specific gene mutation, fusion, copy-number change, or protein level—used to guide targeted clinical care.